In a regulatory filing, Rockwell Automation senior VP Elik I. Fooks disclosed the sale of 7,000 common shares of the company on November 19 at a price of $246.0321 per share.

The company states: "Eiger BioPharmaceuticals announced that the FDA has approved Zokinvy for the treatment of Hutchinson-Gilford Progeria Syndrome, or HGPS, and processing-deficient Progeroid Laminopathies, or PL. Progeria and Progeroid Laminopathies are separate and distinct ultra-rare, genetic, premature aging diseases that accelerate mortality in young patients. Disease manifestations include growth failure, loss of body fat and hair, aged-looking skin, stiffness of joints, hip dislocation, generalized atherosclerosis, cardiovascular disease and stroke. Zokinvy is a disease-modifying agent that has demonstrated a statistically significant survival benefit in children and young adults with Progeria. In patients with Progeria, Zokinvy reduced the incidence of mortality by 60% and increased average survival time by 2.5 years. The most commonly reported adverse reactions were gastrointestinal, and most were mild or moderate in severity. Many Progeria patients have received continuous Zokinvy therapy for more than 10 years."

The board of Medley Capital approved adoption of an internalized management structure effective January 1, 2021. The new management structure will replace the current investment management and administration agreements with MCC Advisors, which expire on December 31. To lead the internalized management team, the board approved the appointment of David Lorber, who has served as an independent director of the company since April 2019, as interim CEO and Ellida McMillan as CFO of the company, each effective January 1, 2021. Lorber and McMillan are in the process of assembling the internalized management team, that will be responsible for the day-to-day management and operations of the company, under the oversight of the board. The company has thus far engaged a senior investment professional with credit experience to serve as the lead portfolio strategist, who will work closely with Lorber. The company is in the process of retaining Alaric Compliance Services, an officer of which would serve as the company's chief compliance officer. The new structure is expected to lead to reduced operating costs and expenses for the company in 2021, although there can be no assurance of the anticipated savings. Lorber, is a co-founder of FrontFour Capital Group, an investment adviser, and has served as a portfolio manager for the firm since January 2007. McMillan, served as CFO and COO of Alcentra Capital.

Manchester United can confirm that the club has experienced a cyber attack on its systems. The club has taken swift actions to contain the attack and is currently working with expert advisers to investigate the incident and minimize the ongoing IT disruption. Although this is a sophisticated operation by organized cyber criminals, the club has extensive protocols and procedures in place for such an event and had rehearsed for this risk. "Our cyber defenses identified the attack and shut down affected systems to contain the damage and protect data," the company said. "Club media channels, including our website and mobile app, are unaffected and we are not currently aware of any breach of personal data associated with our fans or customers. All critical systems required for matches to take place at Old Trafford remain secure and operational and tomorrow's game against West Bromwich Albion will go ahead."

Sysco has been awarded a maximum $136.23M fixed-price with economic-price-adjustment, indefinite-delivery/indefinite-quantity contract for full-line food distribution. This was a competitive acquisition with two responses received. This is a four-year contract with no option periods. Location of performance is Alabama, with a November 23, 2024, ordering period end date. Using customers are Air Force, Army, Marine Corps, Coast Guard and federal civilian agencies. Type of appropriation is FY20 through 2025 defense working capital funds. The contracting agency is the Defense Logistics Agency Troop Support.

In a regulatory filing, Avalara disclosed that its CEO Scott McFarlane sold 55K shares of common stock on November 18th in a total transaction size of $8.82M. The holding represents about 7% of his total owned.

Alaska Air (ALK), JetBlue (JBLU) and others have been awarded firm-fixed-price contracts under the Domestic Airlift Charter Services, Federal Aviation Administration Part 121, indefinite-delivery/indefinite-quantity, fixed-price contract, at estimated program value of $697M. These funds were obligated on individual task orders issued among 16 contracts. The program initially began in October 2018. The contracts provide domestic air cargo and passenger charter services. Services shall be provided for the Department of Defense and other federal government agencies. Work will be performed within the continental U.S., all U.S. territories, Mexico, Canada and the Caribbean Islands. Period of performance is from November 20 to September 30, 2023. Ordering is decentralized and will be determined at the task order level. The U.S. Transportation Command is the contracting activity.

Mannatech announced that its board declared a cash dividend of $1.16 per share of common stock, payable on Wednesday, December 30, to shareholders of record at the close of business on Wednesday, December 16. This dividend combines the quarterly dividend amount of 16c per share with a special dividend amount of $1.00 per share.

The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee on Dec. 10 to discuss the request for emergency use authorization of a COVID-19 vaccine from Pfizer (PFE) in partnership with BioNTech Manufacturing (BNTX). "The FDA recognizes that transparency and dialogue are critical for the public to have confidence in COVID-19 vaccines. I want to assure the American people that the FDA's process and evaluation of the data for a potential COVID-19 vaccine will be as open and transparent as possible," said FDA Commissioner Stephen M. Hahn, M.D. "The FDA has been preparing for the review of EUAs for COVID-19 vaccines for several months and stands ready to do so as soon as an EUA request is submitted. While we cannot predict how long the FDA's review will take, the FDA will review the request as expeditiously as possible, while still doing so in a thorough and science-based manner, so that we can help make available a vaccine that the American people deserve as soon as possible. A discussion about the safety and effectiveness of Pfizer and BioNTech's vaccine with this committee, made up of outside scientific and public health experts from around the country, will help ensure clear public understanding of the scientific data and information that the FDA will evaluate in order to make a decision about whether to authorize a vaccine for emergency use for the prevention of COVID-19."

United Bankshares announced its board of directors declared a fourth quarter dividend of 35c per share for shareholders of record as of December 11, 2020. Dividends per share of $1.40 for the year 2020 represents a 2% increase over the $1.37 per share paid for the year of 2019. The dividend is payable January 4, 2021.

In a regulatory filing, OneMain Holdings chairman Jay N. Levine disclosed the sale of 15,724 common shares of the company on November 18 at a price of $40.329 per share.

U.S. President Donald Trump announced that his administration is issuing two rules to "very dramatically" lower the price of prescription drugs for the American people, especially for seniors. The first action will be to prevent middlemen from "ripping off" Medicare patients with high prescription prices. The second action the administration is finalizing will " transform the way the U.S. government pays for drugs to end global freeloading on the backs of American citizens and American patients," the president said. "Medicare will now look at the price that other developed nations pay for their drugs," Trump added. "And instead of paying the highest price on that list - and we are substantially higher than any other country in the world - we will pay the lowest price. In other words, we take the lowest price, and we match whatever the lowest price is, leading to colossal savings for all Americans. And we're talking about savings of 50, 60, 70 percent, 80 percent - different drugs, different prices." Trump also announced that the White House is ending the Unapproved Drugs Initiative program to put a stop to the "unfair" practice of allowing drug companies to identify certain older generic drugs that have been widely available for decades and exploit a misguided program called "Unapproved Drugs Initiative" to obtain market exclusivity on these medicines. Publicly traded companies in the space include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Reference Link

First Horizon National Corp. the parent company of First Horizon Bank, announced that it would simplify its corporate name to First Horizon Corporation, effective on Monday November 30, 2020. "With the IBERIABANK merger of equals completed, we now have more closely aligned our holding company name with our First Horizon brand," said President and Chief Executive Officer Bryan Jordan.